Internet giants flood into AI drug development: ByteDance, Baidu, Tencent, Alibaba, and JD.com make different choices
Summary
This article compares how ByteDance, Baidu, Tencent, Alibaba, and JD.com are entering AI drug development and broader life sciences software. It shows that each company is using a different model, from ByteDance’s closed-loop R&D and AI-native hospital strategy to Baidu’s platform-first approach and Tencent’s investment-led strategy. It also highlights Alibaba and JD.com as players that use AI to upgrade healthcare services, supply chains, and clinical workflows rather than build drugs directly. The article argues that access to high-quality life science data will determine who can build a durable edge in this market.
Classifications
industries
Engineering
applications
Data Mining
AskAI Classifications
Labels
SaaS
Collaboration Software
Video Editing Software
